Shares of a Traditional Chinese Medicine Maker Plunged by the Daily Limit After the Son of ... - Latest Tweet by Bloomberg

Shares of a traditional Chinese medicine maker plunged by the daily limit after the son of one of China’s richest men questioned the efficacy of its Lianhua Qingwen drug commonly used to treat mild cases of Covid-19 in China https://t.co/JYY70lQm8k— Bloomberg (@business) April 18, 2022

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)